The P2Y12 receptor as a therapeutic target in cardiovascular disease

Author： Storey R. F.  

Publisher： Informa Healthcare

ISSN： 1369-1635

Source： Platelets, Vol.12, Iss.4, 2001-06, pp. : 197-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine A3 Receptor: A promising therapeutic target in cardiovascular disease

By  

Current Cardiology Reviews, Vol. 12, Iss. 1, 2016-02 ,pp. : 18-26

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine A3 Receptor: A promising therapeutic target in cardiovascular disease

By  

Current Cardiology Reviews, Vol. 12, Iss. 1, 2016-01 ,pp. : 18-26

Bentham Science Publishers

Access to resources Recommend Favorite

P2Y12 receptor in platelet activation

By Kim Soochong   Kunapuli Satya P.  

Platelets, Vol. 22, Iss. 1, 2011-02 ,pp. : 54-58

Informa Healthcare

Access to resources Recommend Favorite

Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease

By  

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 93-101

Bentham Science Publishers

Access to resources Recommend Favorite

The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y12 receptor inhibition

By Koessler Juergen   Kobsar Anna L.   Rajkovic Mirjana S.   Schafer Andreas   Flierl Ulrike   Pfoertsch Stephanie   Bauersachs Johann   Steigerwald Udo   Rechner Andreas R.   Walter Ulrich  

Platelets, Vol. 22, Iss. 1, 2011-02 ,pp. : 19-25

Informa Healthcare

Access to resources Recommend Favorite